Scalper1 News
IBD’s top two industries this week are Medical-Biotech/Biomed and Medical-Generic Drugs. Several companies from these top groups reported market-moving news after Tuesday’s market close. Here are five: Akorn Restates, Stock Rises Akorn (AKRX) late Tuesday restated Q2 and Q3 2014 financial statements, citing an error regarding assets and liabilities related to its Hi-Tech Phamacal buy on April 17. The error led to an overstatement of Q2 revenue by Scalper1 News
Scalper1 News